LGA
DGX icon

Lebenthal Global Advisors’s Quest Diagnostics DGX Stock Holding History

Lebenthal Global Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
5,526
+329
+6% +$63.9K 0.16% 103
2025
Q4 		$902K Buy
5,197
+163
+3% +$29.7K 0.14% 105
2025
Q3 		$959K Buy
5,034
+2,720
+118% +$483K 0.17% 91
2025
Q2 		$416K Buy
2,314
+87
+4% +$15.1K 0.08% 146
2025
Q1 		$377K Buy
+2,227
New +$366K 0.07% 154

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Lebenthal Global Advisors's DGX Position: Q1 2026 in Review

Lebenthal Global Advisors increased its Quest Diagnostics (DGX) stake by 6.3% in Q1 2026, buying an estimated $63.9K and bringing the position to 5,526 shares worth $1.08M. The position accounts for 0.16% of the portfolio, ranked #103.

Lebenthal Global Advisors first reported a position in DGX in Q1 2025 and has held it in 5 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Lebenthal Global Advisors held 5,526 shares of Quest Diagnostics worth $1.08M as of Q1 2026.
  • Lebenthal Global Advisors bought 329 Quest Diagnostics shares in Q1 2026, an estimated $63.9K.
  • Quest Diagnostics made up 0.16% of Lebenthal Global Advisors's portfolio in Q1 2026, its #103 holding.
  • Lebenthal Global Advisors first reported a position in Quest Diagnostics in Q1 2025 and has held it in 5 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.